Assura Plc (LON:AGR - Get Free Report)'s stock price crossed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of GBX 39.79 ($0.50) and traded as high as GBX 44.70 ($0.56). Assura shares last traded at GBX 42.96 ($0.54), with a volume of 13,008,762 shares.
Assura Stock Down 1.0 %
The company has a current ratio of 0.89, a quick ratio of 2.84 and a debt-to-equity ratio of 85.05. The company has a market capitalization of £1.36 billion, a P/E ratio of -39.88, a PEG ratio of 3.60 and a beta of 0.37. The stock has a 50 day moving average price of GBX 38.32 and a 200 day moving average price of GBX 39.81.
Assura Dividend Announcement
The company also recently announced a dividend, which was paid on Wednesday, January 15th. Shareholders of record on Thursday, December 12th were given a GBX 0.84 ($0.01) dividend. The ex-dividend date of this dividend was Thursday, December 12th. This represents a yield of 2.12%. Assura's dividend payout ratio is presently -286.76%.
Assura Company Profile
(
Get Free Report)
Assura plc is a specialist healthcare property investor and developer. We enable better health outcomes through our portfolio of more than 600 healthcare buildings across the UK and Ireland, from which over six million patients are served.
We BUILD for health, having developed over 100 new healthcare buildings in our history, and at the heart of our strategy sits The Bigger Picture; Healthy Environment (E), Healthy Communities (S), Healthy Business (G).
Assura plc achieved B Corp certification in July 2024 - the first FTSE 250 business to do so.
See Also
Before you consider Assura, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Assura wasn't on the list.
While Assura currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
